Singapore: The new mobile integrated EMR technology, developed by Fujitsu, a Japanese multinational information technolo...
Singapore: Japan's Chugai Pharmabody Research (CPR) has started its operations in Singapore. The company started operati...
Singapore: Eisai, US, subsidiary of Tokyo-based Eisai, has appointed Mr Yuji Matsue as chairman and chief executive offi...
Singapore: Japan-headquartered global firm, Takeda Pharmaceutical, appointed Mr François-Xavier Roger as its chie...
Singapore: Japan-based Eisai has filed two products, Halaven (eribulin) for metastatic breast cancer and Fycompa (peramp...
Singapore: Otsuka Pharmaceutical and H Lundbeck's submission of a marketing authorization application (MAA) for the a...
Singapore: Santen, a wholly owned subsidiary of Japan-based Santen Pharmaceuticals, and Clearside Biomedical, announc...
Singapore: India based information technology, consulting and outsourcing company, Wipro, has partenerd with Japan's Tak...
Singapore: Affymax and Takeda Pharma decided to voluntarily recall all lots of Omontys (peginesatide) injection to the u...
Singapore: Japanese company Astellas Pharma has completed patient recruitment for the isavuconazole phase III registrati...
Singapore: The European Medicines Agency has accepted a marketing authorization application for alogliptin, a selective ...
Singapore: Japan-based Daiichi Sankyo has decided to expand its collaborative drug discovery program with universities a...
Singapore: Australian infectious disease therapy development company BioDiem has been granted a key Japanese patent f...
Singapore: Zecotek Photonics, a developer of leading-edge photonics technologies for medical, industrial and scientific ...
Singapore: Israel-based Oramed Pharmaceuticals, a developer of oral drug delivery systems, has announced receiving two a...
Singapore: Novo Nordisk announced that the Japanese Ministry of Health, Labour and Welfare has approved RyzodegÂÂ...
Singapore: Japanese company Mitsubishi Tanabe Pharma and Canada-based Cytochroma have terminated a license agreement exe...
When the Indian generic sector forayed into the global arena almost two decades back, the affordability of its treatment...
Singapore: Positive results were reported from Takeda Pharmaceutical's international, randomized, placebo-controll...
Singapore: ReproCELL, a Japanese stem cell technology company, has opened the company's first branch and US office in Bo...
Singapore: Japanese pharmaceutical company Kyowa Hakko Kirin temporarily suspended patient enrollment in an internationa...
Singapore: "BIOtech 2013 in Japan", which recorded significant growth both in the scale and the quality, concluded in hu...
Singapore: A large-scale retrospective database analysis on atorvastatin (Lipitor) by Astellas Pharma and Pfizer Japan h...
Singapore: Medivation and Astellas Pharma have established an updated interim analysis plan for the Prevail trial, a glo...
Singapore: The Indian Department of Commerce is showcasing the achievement of the country's pharmaceutical sector at the...
